tirzepatide egfr cut-off uEGF/Cr and kidney outcomes in CKD. Higher baseline levels predicted lower risk. One-year increases pointed to better outcomes independent of and albuminuria. SGLT2 inhibitors slowed decline, with consistent findings across diverse Renal Outcomes of GLP-1 Receptor

You may also experience more stomach-related side effects like nausea or diarrhoea

10.1016/S0006-8993(00)02373-8 349

Calories do matter, but many other factors are at play

Follow-up consultations include the same components for subsequent months

Recognizing Safe Exercise Intensity While on GLP-1 Medication You can safely perform moderate-to-vigorous exercise while taking semaglutide injections, but listening to your body becomes essential during the adjustment phase

Oral options may expand access and offer more flexibility, which could play an important role in long-term treatment adherence and individualized care, said Yu-Lun Liu, co-author of the study and Associate Professor of Biostatistics at UT Southwestern Medical Center